PMID-sentid Pub_year Sent_text comp_official_name comp_offset protein_name organism prot_offset 31835456-6 2019 Consistently, in the H2O2-treated IPEC-1 cells, fucoidan normalized the content of reduced glutathione as well as the mRNA abundance of NAD(P)H quinone dehydrogenase 1 and superoxide dismutase 1 while it prevented the overproduction of malondialdehyde. Water 21-25 NAD(P)H quinone dehydrogenase 1 Sus scrofa 136-167 9374753-4 1997 Almost all neuronal cell bodies in the SPG and nerve fibers in pial veins and the anterior cerebral arteries that were reactive to ASS, ASL, and NOS were also stained positively with NADPHd, suggesting that ASS, ASL, and NOS were colocalized in the same neurons in the SPG and perivascular nerves. spirogermanium 39-42 NAD(P)H quinone dehydrogenase 1 Sus scrofa 183-189 9374753-4 1997 Almost all neuronal cell bodies in the SPG and nerve fibers in pial veins and the anterior cerebral arteries that were reactive to ASS, ASL, and NOS were also stained positively with NADPHd, suggesting that ASS, ASL, and NOS were colocalized in the same neurons in the SPG and perivascular nerves. spirogermanium 269-272 NAD(P)H quinone dehydrogenase 1 Sus scrofa 183-189 7560908-12 1995 In the pterygopalatine, trigeminal and sensory ganglia of the vagal nerve the vast majority of neurons were NADPH-d-positive. pterygopalatine 7-22 NAD(P)H quinone dehydrogenase 1 Sus scrofa 108-115 33256856-7 2021 Furthermore, CP-Zn decreased the content of MDA and ROS, enhanced the activity of T-SOD and GSH-px, and upregulated the expression levels of Nrf2 pathway-related proteins (Nrf2, NQO1 and HO1) in LPS-stimulated IPEC-J2 cells. cp-zn 13-18 NAD(P)H quinone dehydrogenase 1 Sus scrofa 178-182 32073012-6 2020 In addition, dietary PQQ increased (P < 0.05) the mRNA levels of antioxidant genes (NQO1, UGT1A1, and EPHX1), thereby enhancing (oxidized) nicotinamide adenine dinucleotide (NAD+) concentration and sirtuin 1 (SIRT1) activity in tissues. PQQ Cofactor 21-24 NAD(P)H quinone dehydrogenase 1 Sus scrofa 87-91 32213933-9 2020 Additionally, dietary curcumin enhanced protein (NQO1) and mRNA expression of genes (Nrf2, NQO1, gamma-glutamyltransferase 1 (GGT1), heme oxygenase-1 (HO-1), glutathione S-transferase (GST) and catalase (CAT)) as compared to the IUGR group (p < 0.05). Curcumin 22-30 NAD(P)H quinone dehydrogenase 1 Sus scrofa 49-53 32213933-9 2020 Additionally, dietary curcumin enhanced protein (NQO1) and mRNA expression of genes (Nrf2, NQO1, gamma-glutamyltransferase 1 (GGT1), heme oxygenase-1 (HO-1), glutathione S-transferase (GST) and catalase (CAT)) as compared to the IUGR group (p < 0.05). Curcumin 22-30 NAD(P)H quinone dehydrogenase 1 Sus scrofa 91-95 31878265-4 2019 Results of real-time PCR showed that the IUGR + CUR group significantly increased the gene expression of NF-E2-related factor 2 (Nrf2) (p < 0.05), and increased the glutamate-cysteine ligase catalytic subunit (GCLC), superoxide dismutase 1 (SOD1), glutamate-cysteine ligase modifier subunit (GCLM), and NAD(P)H quinone dehydrogenase 1 (NQO1) mRNA expression compared with the IUGR group (p < 0.05). CUR-N beta-1,3-glucan 48-51 NAD(P)H quinone dehydrogenase 1 Sus scrofa 306-337 31878265-4 2019 Results of real-time PCR showed that the IUGR + CUR group significantly increased the gene expression of NF-E2-related factor 2 (Nrf2) (p < 0.05), and increased the glutamate-cysteine ligase catalytic subunit (GCLC), superoxide dismutase 1 (SOD1), glutamate-cysteine ligase modifier subunit (GCLM), and NAD(P)H quinone dehydrogenase 1 (NQO1) mRNA expression compared with the IUGR group (p < 0.05). CUR-N beta-1,3-glucan 48-51 NAD(P)H quinone dehydrogenase 1 Sus scrofa 339-343 31878265-5 2019 Western blot results showed that dietary supplementation with 200 mg/kg curcumin significantly increased the protein levels of Nrf2 and NQO1. Curcumin 72-80 NAD(P)H quinone dehydrogenase 1 Sus scrofa 136-140 31835456-6 2019 Consistently, in the H2O2-treated IPEC-1 cells, fucoidan normalized the content of reduced glutathione as well as the mRNA abundance of NAD(P)H quinone dehydrogenase 1 and superoxide dismutase 1 while it prevented the overproduction of malondialdehyde. fucoidan 48-56 NAD(P)H quinone dehydrogenase 1 Sus scrofa 136-167 30062552-6 2018 Hydroquinone, the end product of quinone metabolism by NQO-1, augmented contractions depending on sGC activation but in an endothelium-independent manner. hydroquinone 0-12 NAD(P)H quinone dehydrogenase 1 Sus scrofa 55-60 30606113-10 2019 Biological processes identified for co-localized eQTL genes include calcium signaling (FERM, MRLN, PKP2 and CHRNA9), energy metabolism (SUCLG2 and PFKFB3) and redox hemostasis (NQO1 and CEP128), and results support an important role for activation of the PI3K-Akt-mTOR signaling pathway during the initial conversion of muscle to meat. Calcium 68-75 NAD(P)H quinone dehydrogenase 1 Sus scrofa 177-181 30062552-6 2018 Hydroquinone, the end product of quinone metabolism by NQO-1, augmented contractions depending on sGC activation but in an endothelium-independent manner. quinone 5-12 NAD(P)H quinone dehydrogenase 1 Sus scrofa 55-60 30062552-7 2018 In coronary arteries, repeated acute hypoxia caused similar augmentations as those to quinones that were inhibited by the NQO-1 inhibitor dicoumarol. Quinones 86-94 NAD(P)H quinone dehydrogenase 1 Sus scrofa 122-127 30062552-7 2018 In coronary arteries, repeated acute hypoxia caused similar augmentations as those to quinones that were inhibited by the NQO-1 inhibitor dicoumarol. Dicumarol 138-148 NAD(P)H quinone dehydrogenase 1 Sus scrofa 122-127 30062552-8 2018 Augmentations of contraction observed with different naturally occurring quinones and with acute hypoxia are initiated by quinone metabolism by NQO-1, in turn interfering with the NO/biased sGC pathway, suggesting a possibly detrimental role of this enzyme in ischemic cardiovascular disorders. Quinones 73-81 NAD(P)H quinone dehydrogenase 1 Sus scrofa 144-149 30062552-8 2018 Augmentations of contraction observed with different naturally occurring quinones and with acute hypoxia are initiated by quinone metabolism by NQO-1, in turn interfering with the NO/biased sGC pathway, suggesting a possibly detrimental role of this enzyme in ischemic cardiovascular disorders. quinone 73-80 NAD(P)H quinone dehydrogenase 1 Sus scrofa 144-149 20732396-5 2010 The protective effect of SFN on ROS production and cell viability was prevented by buthionine sulfoximine (BSO), an inhibitor of gammaGCL, and by dicoumarol, an inhibitor of NQO1. Dicumarol 146-156 NAD(P)H quinone dehydrogenase 1 Sus scrofa 174-178 30062552-4 2018 beta-lapachone, an ortho-quinone and hence substrate of NQO-1, increased the activity of the enzyme and augmented contractions in arteries with endothelium. beta-lapachone 0-14 NAD(P)H quinone dehydrogenase 1 Sus scrofa 56-61 30062552-4 2018 beta-lapachone, an ortho-quinone and hence substrate of NQO-1, increased the activity of the enzyme and augmented contractions in arteries with endothelium. 2-benzoquinone 19-32 NAD(P)H quinone dehydrogenase 1 Sus scrofa 56-61